ClinicalTrials.Veeva

Menu

Reference Interval Validation of High-Sensitivity Cardiac Troponin T Assay in Thai Population

C

Chulalongkorn University

Status

Completed

Conditions

Diagnoses Disease

Treatments

Device: SYSMEX HLSCL

Study type

Interventional

Funder types

Other

Identifiers

NCT03968016
Troponin T

Details and patient eligibility

About

The investigators aimed to study the cut-off of high sensitivity troponin T using SYSMEX HLSCL Machine in Thai population at percentile 99.

Enrollment

120 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

For healthy group

Inclusion Criteria:

  • Group 1: Aged 18 - 40 years
  • Group 2: Aged > 40 - 70 years
  • A presumably healthy population will define from a health questionnaire

Exclusion Criteria:

  • Heart diseases
  • Renal diseases (CKD or recent AKI)
  • History of pulmonary embolism

For Patient group with stable heart diseases

Inclusion Criteria:

  • Aged > 40 - 70 years
  • Stable heart disease individuals will be evaluated by cardiologist
  • Non hospitalized (OPD settings)

Exclusion Criteria:

  • Stable heart diseases with ACS
  • Renal diseases (CKD or recent AKI)
  • History of pulmonary embolism

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

120 participants in 2 patient groups, including a placebo group

Healthy
Placebo Comparator group
Description:
Control group
Treatment:
Device: SYSMEX HLSCL
Stable heart disease
Active Comparator group
Description:
Stable heart disease and non-hospitalized
Treatment:
Device: SYSMEX HLSCL

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems